rss
J Am Med Inform Assoc 15:647-653 doi:10.1197/jamia.M2634
  • Original Investigation

Can Surveillance Systems Identify and Avert Adverse Drug Events? A Prospective Evaluation of a Commercial Application

Table 3

Frequency of Alert Drug and Lab for all ADEs and Potential ADEs Detected in Alerts with MD contact (N=15)

Alert Drug Alert Lab Number of Alerts Adverse Event
ADEs
 Sulindac Serum Creatinine 1 Renal Failure
 Famotidine Low Platelet Count 1 Bleeding
 Digoxin Serum Creatinine 1 Arrhythmia
 Carbamazepine Pancytopenia 1 Worsening infection
 Total 4
Potential ADEs
 Vancomycin Serum Creatinine 3 Markedly elevated vancomycin levels
 Levofloxacin Serum Creatinine 3 Inappropriately high levofloxacin dose
 Enoxaparin Low Platelet Count 2 Potential bleeding
 Enoxaparin Serum Creatinine 1 Potential bleeding
 Clopidogrel, aspirin Low Platelet Count 1 Potential bleeding
 NSAIDs, Aspirin Serum Creatinine 1 Potential bleeding
 Total 11
  • ADE = adverse drug effect; PADE = potential adverse drug effect.

This Article

Access policy for JAMIA

All content published in JAMIA is deposited with PubMed Central by the publisher with a 12 month embargo. Authors/funders may pay an Unlocked fee of $2,000 to make the article free on the JAMIA website and PMC immediately on publication.

All content older than 12 months is freely available on this website.

AMIA members can log in with their JAMIA user name (email address) and password or via the AMIA website.